Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 EUR | +4.20% | -3.25% | -87.92% |
Sales 2024 * | 39.35M 36.29M 3.27B | Sales 2025 * | 58.17M 53.64M 4.83B | Capitalization | 75.81M 69.9M 6.3B |
---|---|---|---|---|---|
Net income 2024 * | -120M -111M -9.96B | Net income 2025 * | -77M -71M -6.39B | EV / Sales 2024 * | -1.31 x |
Net cash position 2024 * | 127M 118M 10.58B | Net cash position 2025 * | 54.53M 50.28M 4.53B | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-1.33
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 week | +2.48% | ||
Current month | -4.62% | ||
1 month | -3.88% | ||
3 months | -85.91% | ||
6 months | -78.43% | ||
Current year | -87.41% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/21/12 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/19/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/08/01 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/19/12 |
Date | Price | Change |
---|---|---|
24/24/24 | 1.24 | +4.20% |
23/24/23 | 1.19 | -4.80% |
22/24/22 | 1.25 | +3.31% |
21/24/21 | 1.21 | +0.83% |
20/24/20 | 1.2 | -0.83% |
Delayed Quote Börse Stuttgart, May 24, 2024 at 11:08 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock